Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 3.250% 2/0
-
Market price (% of par)
-
221.27%
-
Total 13F principal
-
$105,112,000
-
Principal change
-
-$4,009,000
-
Total reported market value
-
$232,506,000
-
Number of holders
-
15
-
Value change
-
-$9,008,968
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of PACIRA PHARMACEUTICALS INC - NOTE 3.250% 2/0 as of Q1 2016
As of 31 Mar 2016,
PACIRA PHARMACEUTICALS INC - NOTE 3.250% 2/0 was held by
15 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$105,112,000
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Myriad Asset Management Ltd., WHITEBOX ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, LINDEN ADVISORS LP, FRANKLIN RESOURCES INC, ROYAL BANK OF CANADA, Verition Fund Management LLC, and AMERIPRISE FINANCIAL INC.
This page lists
15
institutional bondholders reporting positions
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.